1nkemia IUCT Group SA
MAD:IKM
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| ES |
|
1nkemia IUCT Group SA
MAD:IKM
|
7.9m EUR |
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
395.1B USD |
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
204.9B USD |
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
190B USD |
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
121.3B USD |
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.5B USD |
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
87.4B AUD |
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
41.9B EUR |
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Market Distribution
| Min | -9 204.1% |
| 30th Percentile | 1.8% |
| Median | 7.6% |
| 70th Percentile | 19% |
| Max | 603.4% |
Other Profitability Ratios
1nkemia IUCT Group SA
Glance View
1nKemia IUCT Group SA engages in the research and development activities related to pharmaceutical, chemical, and biotechnology industries. The company is headquartered in Mollet Del Valles, Barcelona. The company went IPO on 2012-12-21. The firm provides products and services for chemical, pharmaceutical, biopharmaceutical, life science and related industry. The Company’s activity is related to the generation, promotion, development and sale of products and services. The firm transforms its knowledge and know-how into a pipeline of products, processes, services and technological platforms. Its solutions are specialized, integrated and protected by patents. The main areas of expertise are related to drugs development, industrial biotechnology and green chemistry. The firm has a number of subsidiaries, including IUCT SA and IUCT Empren SL.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
Over the last 3 years, 1nkemia IUCT Group SA’s Net Margin has decreased from 13% to -445.3%. During this period, it reached a low of -445.3% on Jan 31, 2019 and a high of 13% on Dec 1, 2015.
